122 related articles for article (PubMed ID: 36227806)
1. Derivation and External Validation of Machine Learning-Based Model for Detection of Pancreatic Cancer.
Chen W; Zhou Y; Xie F; Butler RK; Jeon CY; Luong TQ; Zhou B; Lin YC; Lustigova E; Pisegna JR; Kim S; Wu BU
Am J Gastroenterol; 2023 Jan; 118(1):157-167. PubMed ID: 36227806
[TBL] [Abstract][Full Text] [Related]
2. Machine learning versus regression for prediction of sporadic pancreatic cancer.
Chen W; Zhou B; Jeon CY; Xie F; Lin YC; Butler RK; Zhou Y; Luong TQ; Lustigova E; Pisegna JR; Wu BU
Pancreatology; 2023 Jun; 23(4):396-402. PubMed ID: 37130760
[TBL] [Abstract][Full Text] [Related]
3. A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes.
Boursi B; Finkelman B; Giantonio BJ; Haynes K; Rustgi AK; Rhim AD; Mamtani R; Yang YX
Gastroenterology; 2017 Mar; 152(4):840-850.e3. PubMed ID: 27923728
[TBL] [Abstract][Full Text] [Related]
4. Risk Prediction of Pancreatic Cancer in Patients With Recent-onset Hyperglycemia: A Machine-learning Approach.
Chen W; Butler RK; Lustigova E; Chari ST; Maitra A; Rinaudo JA; Wu BU
J Clin Gastroenterol; 2023 Jan; 57(1):103-110. PubMed ID: 35470312
[TBL] [Abstract][Full Text] [Related]
5. A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data.
Jia K; Kundrot S; Palchuk MB; Warnick J; Haapala K; Kaplan ID; Rinard M; Appelbaum L
EBioMedicine; 2023 Dec; 98():104888. PubMed ID: 38007948
[TBL] [Abstract][Full Text] [Related]
6. Association of Glycated Hemoglobin Levels With Risk of Pancreatic Cancer.
Wu BU; Butler RK; Lustigova E; Lawrence JM; Chen W
JAMA Netw Open; 2020 Jun; 3(6):e204945. PubMed ID: 32530471
[TBL] [Abstract][Full Text] [Related]
7. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Pancreatic Cancer Based on Imaging Features in Patients With Duct Abnormalities.
Chen W; Butler RK; Zhou Y; Parker RA; Jeon CY; Wu BU
Pancreas; 2020 Mar; 49(3):413-419. PubMed ID: 32132511
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
[TBL] [Abstract][Full Text] [Related]
10. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model: A Retrospective Cohort Study Using Real-World Data.
Boursi B; Patalon T; Webb M; Margalit O; Beller T; Yang YX; Chodick G
Pancreas; 2022 Feb; 51(2):196-199. PubMed ID: 35404897
[TBL] [Abstract][Full Text] [Related]
12. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
Yu S; Li Y; Liao Z; Wang Z; Wang Z; Li Y; Qian L; Zhao J; Zong H; Kang B; Zou WB; Chen K; He X; Meng Z; Chen Z; Huang S; Wang P
Gut; 2020 Mar; 69(3):540-550. PubMed ID: 31562239
[TBL] [Abstract][Full Text] [Related]
13. CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal Adenocarcinoma.
Park S; Sham JG; Kawamoto S; Blair AB; Rozich N; Fouladi DF; Shayesteh S; Hruban RH; He J; Wolfgang CL; Yuille AL; Fishman EK; Chu LC
AJR Am J Roentgenol; 2021 Nov; 217(5):1104-1112. PubMed ID: 34467768
[No Abstract] [Full Text] [Related]
14. Predicting the risk of emergency admission with machine learning: Development and validation using linked electronic health records.
Rahimian F; Salimi-Khorshidi G; Payberah AH; Tran J; Ayala Solares R; Raimondi F; Nazarzadeh M; Canoy D; Rahimi K
PLoS Med; 2018 Nov; 15(11):e1002695. PubMed ID: 30458006
[TBL] [Abstract][Full Text] [Related]
15. Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population.
Brewer MJ; Doucette JT; Bar-Mashiah A; Glickman JW; Kessel E; Aronson A; Lucas AL
Clin Gastroenterol Hepatol; 2022 May; 20(5):1105-1111.e2. PubMed ID: 34358720
[TBL] [Abstract][Full Text] [Related]
16. Association between chronic pancreatitis and pancreatic cancer: A 10-year retrospective study of endoscopically treated and surgical patients.
Korpela T; Udd M; Mustonen H; Ristimäki A; Haglund C; Seppänen H; Kylänpää L
Int J Cancer; 2020 Sep; 147(5):1450-1460. PubMed ID: 32162688
[TBL] [Abstract][Full Text] [Related]
17. A review of lifestyle, metabolic risk factors, and blood-based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma.
Pang Y; Holmes MV; Chen Z; Kartsonaki C
J Gastroenterol Hepatol; 2019 Feb; 34(2):330-345. PubMed ID: 30550622
[TBL] [Abstract][Full Text] [Related]
18. Radiomics-based Machine-learning Models Can Detect Pancreatic Cancer on Prediagnostic Computed Tomography Scans at a Substantial Lead Time Before Clinical Diagnosis.
Mukherjee S; Patra A; Khasawneh H; Korfiatis P; Rajamohan N; Suman G; Majumder S; Panda A; Johnson MP; Larson NB; Wright DE; Kline TL; Fletcher JG; Chari ST; Goenka AH
Gastroenterology; 2022 Nov; 163(5):1435-1446.e3. PubMed ID: 35788343
[TBL] [Abstract][Full Text] [Related]
19. Multicenter study of early pancreatic cancer in Japan.
Kanno A; Masamune A; Hanada K; Maguchi H; Shimizu Y; Ueki T; Hasebe O; Ohtsuka T; Nakamura M; Takenaka M; Kitano M; Kikuyama M; Gabata T; Yoshida K; Sasaki T; Serikawa M; Furukawa T; Yanagisawa A; Shimosegawa T;
Pancreatology; 2018 Jan; 18(1):61-67. PubMed ID: 29170051
[TBL] [Abstract][Full Text] [Related]
20. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]